学科服务

学科服务简介
收录引用证明
相似性检测
委托指南
收费标准及缴费方式
ESI排名及高水平论文榜单
ESI期刊目录
QQ在线咨询

ESI排名及高水平论文榜单

我校ESI排名及高水平论文榜单(2025年1月)

ESI的22个学科中,目前我校已有3个学科进入ESI全球前1%排名,分别是:临床医学、药理学与毒理学生物学与生物化学,临床医学学科进入全球排名3图书馆按照ESI更新时间(每两个月滚动更新一次)定期整理我校ESI相关数据,为我校ESI学科建设提供强有力支持,助推ESI学科的持续快速发展。现将本期我校ESI学科及高水平论文整理如下:

一、我校ESI学科概况

根据美国基本科学指标(Essential Science Indicator,ESI)2025年1月9日最新数据(数据覆盖时间范围为2014年1月1日-2024年10月31日)显示,我校临床医学、药理学与毒理学学科生物学与生物化学仍保持在全球ESI学科前1%排名之列具体见图1。

1 贵州医科大学ESI学科情况(20251月)

1.临床医学ESI表现情况

本期全球共有6619个机构临床医学学科入围ESI全球前1%排名,我校临床医学学科全球排名1921位(上期排名1947/6518),其中中国大陆共有248家机构入围,我校排名92位(上期排名93/246),国内共有175所高校入围,我校排名73位(上期排名73/172),全球排名上升0.8个百分点,国内排名上升0.7个百分点。临床医学本期ESI具体表现统计情况见表1,检索截图见图2。

1-贵州医科大学ESI学科(临床医学)科研表现/排名(2025年1月)

2 贵州医科大学临床医学ESI表现(20251月)

2.药理与毒理学ESI表现情况

本期全球共有1361个机构药理学与毒理学学科入围ESI全球前1%排名,我校全球排名596位(上期排名600/1337),其中中国大陆共有170家机构入围ESI,我校排名81位(上期排名81/168),国内共有136所高校入围,我校排名69位(上期排名69/134),全球排名上升1.1个百分点,国内排名上升0.8个百分点。药理学与毒理学本期ESI具体表现统计情况见表2,检索截图见图3。

2-贵州医科大学ESI学科(药理学与毒理学)科研表现/排名情况(2025年1月)

3 贵州医科大学药理学与毒理学ESI表现(20251月)

3.生物学与生物化学ESI表现情况

本期全球共有1604个机构生物学与生物化学学科入围ESI全球前1%排名,我校生物学与生物全球排名1463位(上期排名1472/1576),其中中国大陆共有194家机构入围ESI,我校排名168位(上期排名168/187),国内共有148所高校入围,我校排名134位(上期排名134/144),全球排名上升2.2个百分点,国内排名上升2.5个百分点。生物学与生物化学本期ESI具体表现统计情况见表3,检索截图见图4。

  3-贵州医科大学ESI学科(生物学与生物化学)科研表现/排名情况(2025年1月)

4 贵州医科大学生物学与生物化学ESI表现(20251月)

、我校高水平论文(高被引论文和热点论文)

高水平论文是高被引论文和热点论文取并集后的论文集合其中高被引论文和热点论文的定义如下:高被引论文(Highly Cited Paper):根据同一年同一ESI学科统计最近10年发表论文中被引用次数进入世界前1%的论文;热点论文(Hot Paper):按ESI学科统计最近两年发表、在最近两个月里被引用次数进入世界前0.1%的论文。

本期我校共有高水平论文70篇(其中高被引论文69篇,热点论文7同时为高水平论文,其中6篇为高被引论文),其中临床医学有高水平论文36篇(高被引论文36,热点论文4篇),药理学与毒理学有高水平论文4篇(高被引论文4篇)生物学与生物化学有高水平论文2篇(高被引论文2篇)。上期高水平论文为68篇,较上期相比,新增高水平论文(高被引论文)6篇,减少4篇,其余64篇高水平论文仍保持在列本期我校高水平论文学科分布情况见图5,高水平论文具体情况见表4

5 我校高水平论文数量及学科分布

4-本期我校高水平论文一览表

序号

标题

作者及贡献

机构

来源

学科

被引频次

发表年

类型

1

PREVALENCE OF DIABETES RECORDED IN MAINLAND CHINA USING 2018 DIAGNOSTIC CRITERIA FROM THE AMERICAN DIABETES ASSOCIATION: NATIONAL CROSS SECTIONAL STUDY

Zhang, Qiao/参与

贵州医科大学

BMJ-BRITISH MEDICAL JOURNAL 369: - APR 28 2020

CLINICAL MEDICINE

912

2020

高被引论文

2

PREVALENCE, RISK FACTORS, AND MANAGEMENT OF DEMENTIA AND MILD COGNITIVE IMPAIRMENT IN ADULTS AGED 60 YEARS OR OLDER IN CHINA: A CROSS-SECTIONAL STUDY

Chu, Lan/参与作者

贵州医科大学附属医院

LANCET PUBLIC HEALTH 5 (12): E661-E671 DEC 2020

SOCIAL SCIENCES, GENERAL

697

2020

高被引论文

3

GEMCITABINE AND CISPLATIN INDUCTION CHEMOTHERAPY IN NASOPHARYNGEAL CARCINOMA

Su, Shengfa/第二作者

贵州医科大学

NEW ENGLAND JOURNAL OF MEDICINE 381 (12): 1124-1135 SEP 19 2019

CLINICAL MEDICINE

548

2019

高被引论文

4

OUTLINE OF FUNGI AND FUNGUS-LIKE TAXA

Li, Q. RKang, Y/参与

贵州医科大学

MYCOSPHERE 11 (1): 1060-1456 2020

PLANT & ANIMAL SCIENCE

503

2020

高被引论文

5

DEMENTIA IN CHINA: EPIDEMIOLOGY, CLINICAL MANAGEMENT, AND RESEARCH ADVANCES

Chu, Lan/参与

贵州医科大学

LANCET NEUROLOGY 19 (1): 81-92 JAN 2020

NEUROSCIENCE & BEHAVIOR

444

2020

高被引论文

6

STANDARDS OF MEDICAL CARE FOR TYPE 2 DIABETES IN CHINA 2019

Shi, Lixin/参与

贵州医科大学

DIABETES-METABOLISM RESEARCH AND REVIEWS 35 (6): - SEP 2019

CLINICAL MEDICINE

427

2019

高被引论文

7

LONG-TERM OUTCOMES OF INTENSITY-MODULATED RADIOTHERAPY FOR 868 PATIENTS WITH NASOPHARYNGEAL CARCINOMA: AN ANALYSIS OF SURVIVAL AND TREATMENT TOXICITIES

Su, Shengfa/第二作者

贵州医科大学

RADIOTHERAPY AND ONCOLOGY 110 (3): 398-403 MAR 2014

CLINICAL MEDICINE

422

2014

高被引论文

8

THE COST OF ALZHEIMERS DISEASE IN CHINA AND RE-ESTIMATION OF COSTS WORLDWIDE

Chu, Lan/参与

贵州医科大学附属医院

ALZHEIMERS & DEMENTIA 14 (4): 483-491 APR 2018

NEUROSCIENCE & BEHAVIOR

399

2018

高被引论文

9

TRIAL OF ENDOVASCULAR THERAPY FOR ACUTE ISCHEMIC STROKE WITH LARGE INFARCT

Ren, Zeguang/通讯作者;

贵州医科大学附属医院

NEW ENGLAND JOURNAL OF MEDICINE 388 (14): 1272-1283 APR 6 2023

CLINICAL MEDICINE

322

2023

高被引论文、热点论文

10

ACUTE KIDNEY INJURY IN CHINA: A CROSS-SECTIONAL SURVEY

Zha, Yan/参与

贵州医科大学

LANCET 386 (10002): 1465-1471 OCT 10 2015

CLINICAL MEDICINE

316

2015

高被引论文

11

LOSS OF SUPER-ENHANCER-REGULATED CIRCRNA NFIX INDUCES CARDIAC REGENERATION AFTER MYOCARDIAL INFARCTION IN ADULT MICE

Si, Xiaoyun;Li, Bing/参与

贵州医科大学附属医院

CIRCULATION 139 (25): 2857-2876 JUN 18 2019

CLINICAL MEDICINE

297

2019

高被引论文

12

THE PREVALENCE OF DEMENTIA IN URBAN AND RURAL AREAS OF CHINA

Chu, Lan/参与

贵阳医学院附属医院

ALZHEIMERS & DEMENTIA 10 (1): 1-9 JAN 2014

NEUROSCIENCE & BEHAVIOR

290

2014

高被引论文

13

TRIAL OF THROMBECTOMY 6 TO 24 HOURS AFTER STROKE DUE TO BASILAR-ARTERY OCCLUSION

Yang, H/参与

贵州医科大学附属医院

NEW ENGLAND JOURNAL OF MEDICINE 387 (15): 1373-1384 OCT 13 2022

CLINICAL MEDICINE

278

2022

高被引论文

14

MOLECULAR MECHANISMS FOR TUMOUR RESISTANCE TO CHEMOTHERAPY

He, ZhiXu/通讯作者

贵州医科大学

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY 43 (8): 723-737 AUG 2016

PHARMACOLOGY & TOXICOLOGY

277

2016

高被引论文

15

EFFICACY AND SAFETY OF THREE NEW ORAL ANTIVIRAL TREATMENT (MOLNUPIRAVIR, FLUVOXAMINE AND PAXLOVID) FOR COVID-19: A META-ANALYSIS

Cheng, Yongran/参与;Feng, Zhanhui/通讯作者

贵州医科大学附属医院

ANNALS OF MEDICINE 54 (1): 516-523 DEC 31 2022

CLINICAL MEDICINE

258

2022

高被引论文

16

COMBINATION IMMUNOTHERAPY OF MUC1 MRNA NANO-VACCINE AND CTLA-4 BLOCKADE EFFECTIVELY INHIBITS GROWTH OF TRIPLE NEGATIVE BREAST CANCER

Liu, Lina/第一作者

贵州医科大学

MOLECULAR THERAPY 26 (1): 45-55 JAN 3 2018

CLINICAL MEDICINE

244

2018

高被引论文

17

STANDARDS OF CARE FOR TYPE 2 DIABETES IN CHINA

Shi, Lixin/参与

贵州医科大学

DIABETES-METABOLISM RESEARCH AND REVIEWS 32 (5): 442-458 SP. ISS. SI JUL 2016

CLINICAL MEDICINE

242

2016

高被引论文

18

CHINESE TIME TRADE-OFF VALUES FOR EQ-5D HEALTH STATES

Wu, Hongyan/第二作者

贵州医科大学

VALUE IN HEALTH 17 (5): 597-604 JUL 2014

PHARMACOLOGY & TOXICOLOGY

240

2014

高被引论文

19

IMMUNE INFILTRATION IN RENAL CELL CARCINOMA

Zhang, Shichao/第一作者;Ouyang, Yan; Zeng, Zhu/通讯作者;Long, Jinhua;Hu, Zuquan;Peng, Jian;Liu, Lina;Tang, Fuzhou/均为参与

贵州医科大学

CANCER SCIENCE 110 (5): 1564-1572 MAY 2019

CLINICAL MEDICINE

226

2019

高被引论文

20

CONCORDANCE BETWEEN THE ASSESSMENT OF A BETA 42, T-TAU, AND P-T181-TAU IN PERIPHERAL BLOOD NEURONAL-DERIVED EXOSOMES AND CEREBROSPINAL FLUID

Chu, Lan/参与

贵州医科大学附属医院

ALZHEIMERS & DEMENTIA 15 (8): 1071-1080 AUG 2019

NEUROSCIENCE & BEHAVIOR

222

2019

高被引论文

21

TORIPALIMAB OR PLACEBO PLUS CHEMOTHERAPY AS FIRST-LINE TREATMENT IN ADVANCED NASOPHARYNGEAL CARCINOMA: A MULTICENTER RANDOMIZED PHASE 3 TRIAL

Jin, Feng/参与

贵州医科大学

NATURE MEDICINE 27 (9): 1536-+ SEP 2021

MOLECULAR BIOLOGY & GENETICS

220

2021

高被引论文

22

FAMILIES OF SORDARIOMYCETES

Li, QiRui/参与

贵阳医学院

FUNGAL DIVERSITY 79 (1): - JUL 2016

PLANT & ANIMAL SCIENCE

218

2016

高被引论文

23

TAGITININ C INDUCES FERROPTOSIS THROUGH PERK-NRF2-HO-1 SIGNALING PATHWAY IN COLORECTAL CANCER CELLS

Wei, Ruiran/第一作者;Gui, Liming/通讯作者

贵州医科大学

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES 17 (11): 2703-2717 2021

BIOLOGY & BIOCHEMISTRY

210

2021

高被引论文

24

AUTOPHAGY AND INFLAMMATION IN ISCHEMIC STROKE

Mo, Yun/第一作者

贵州医科大学

NEURAL REGENERATION RESEARCH 15 (8): 1388-1396 AUG 2020

NEUROSCIENCE & BEHAVIOR

201

2020

高被引论文

25

ESTIMATED BURDEN OF STROKE IN CHINA IN 2020

Chu, Lan/参与

贵州医科大学附属医院

JAMA NETWORK OPEN 6 (3): - MAR 2023

CLINICAL MEDICINE

194

2023

高被引论文、热点论文

26

MULTICENTER, RANDOMIZED, PHASE III TRIAL OF SHORT-TERM RADIOTHERAPY PLUS CHEMOTHERAPY VERSUS LONG-TERM CHEMORADIOTHERAPY IN LOCALLY ADVANCED RECTAL CANCER (STELLAR)

Wang, WenLing/参与

贵州医科大学附属医院

JOURNAL OF CLINICAL ONCOLOGY 40 (15): 1681-+ MAY 20 2022

CLINICAL MEDICINE

193

2022

高被引论文

27

SEPSIS-INDUCED IMMUNOSUPPRESSION: MECHANISMS, DIAGNOSIS AND CURRENT TREATMENT OPTIONS

Deng, Jin/参与

贵州医科大学附属医院

MILITARY MEDICAL RESEARCH 9 (1): - OCT 9 2022

CLINICAL MEDICINE

190

2022

高被引论文

28

DEVELOPMENT OF PURPLE ENDOSPERM RICE BY ENGINEERING ANTHOCYANIN BIOSYNTHESIS IN THE ENDOSPERM WITH A HIGH-EFFICIENCY TRANSGENE STACKING SYSTEM

Liu, Hongmei/参与

贵州医科大学

MOLECULAR PLANT 10 (7): 918-929 JUL 5 2017

PLANT & ANIMAL SCIENCE

188

2017

高被引论文

29

EFFICACY AND SAFETY OF LONG-TERM UNIVERSAL SALT IODIZATION ON THYROID DISORDERS: EPIDEMIOLOGICAL EVIDENCE FROM 31 PROVINCES OF MAINLAND CHINA

Zhang, Q/参与

贵阳医学院

THYROID 30 (4): 568-579 APR 1 2020

BIOLOGY & BIOCHEMISTRY

186

2020

高被引论文

30

IMBALANCED GSH/ROS AND SEQUENTIAL CELL DEATH

Liu, Ting/第一作者;Zheng, Jiang/通讯作者; Sun, LiZhang, YubinWang, Yonglin/均为参与

贵州医科大学

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY 36 (1): - JAN 2022

PHARMACOLOGY & TOXICOLOGY

173

2022

高被引论文

31

ULTRA-STRETCHABLE AND FAST SELF-HEALING IONIC HYDROGEL IN CRYOGENIC ENVIRONMENTS FOR ARTIFICIAL NERVE FIBER

Zheng, Qiang/参与

贵州医科大学

ADVANCED MATERIALS 34 (16): - APR 2022

MATERIALS SCIENCE

170

2022

高被引论文

32

ABSORPTION, METABOLISM AND BIOAVAILABILITY OF FLAVONOIDS: A REVIEW

Huang, Qun/参与

贵州医科大学

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION 62 (28): 7730-7742 OCT 3 2022

AGRICULTURAL SCIENCES

149

2022

高被引论文

33

1,8-CINEOLE: A REVIEW OF SOURCE, BIOLOGICAL ACTIVITIES, AND APPLICATION

Cai, Zi-Min/第一作者;
Peng, Jian-Qing;
Shen, Xiang-Chun/通讯作者

贵州医科大学

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH 23 (10): 938-954 OCT 3 2021

PHARMACOLOGY & TOXICOLOGY

128

2021

高被引论文

34

CHANGES IN VOLATILE FLAVOR OF YAK MEAT DURING OXIDATION BASED ON MULTI-OMICS

Huang, Qun/第一作者;Luo, Peng/通讯作者

贵州医科大学

FOOD CHEMISTRY 371: - MAR 1 2022

AGRICULTURAL SCIENCES

124

2022

高被引论文

35

ASSOCIATION BETWEEN SLEEP DURATION AND DEPRESSION IN US ADULTS: A CROSS-SECTIONAL STUDY

Dong, Lu/第一作者;Zou, Xiaohua/通讯作者

贵州医科大学附属医院

JOURNAL OF AFFECTIVE DISORDERS 296: 183-188 JAN 1 2022

PSYCHIATRY/PSYCHOLOGY

115

2022

高被引论文

36

METRONOMIC CAPECITABINE AS ADJUVANT THERAPY IN LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA: A MULTICENTRE, OPEN-LABEL, PARALLEL-GROUP, RANDOMISED, CONTROLLED, PHASE 3 TRIAL

Jin, FengLuo, XiuLing/参与

贵州医科大学附属医院

LANCET 398 (10297): 303-313 JUL 24 2021

CLINICAL MEDICINE

112

2021

高被引论文

37

SYNTHESIS, ANTIOXIDANT AND ANTI-TYROSINASE ACTIVITY OF 1,2,4-TRIAZOLE HYDRAZONES AS ANTIBROWNING AGENTS

Wang, Guangcheng/第二作者

贵州医科大学

FOOD CHEMISTRY 341: - PART 2 MAR 30 2021

AGRICULTURAL SCIENCES

109

2021

高被引论文

38

ANXIETY, DEPRESSION, AND STRESS PREVALENCE AMONG COLLEGE STUDENTS DURING THE COVID-19 PANDEMIC: A SYSTEMATIC REVIEW AND META-ANALYSIS

Ye, LanFeng, Zhanhui/参与

贵州医科大学;贵州医科大学附属医院

JOURNAL OF AMERICAN COLLEGE HEALTH 71 (7): 2123-2130 JUL 26 2021

SOCIAL SCIENCES, GENERAL

104

2021

高被引论文

39

EXPOSURE TO AIR POLLUTION IS ASSOCIATED WITH AN INCREASED RISK OF METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE

Wang, Ziyun/参与

贵州医科大学

JOURNAL OF HEPATOLOGY 76 (3): 518-525 MAR 2022

CLINICAL MEDICINE

102

2022

高被引论文

40

A LIBRARY OF ROS-CATALYTIC METALLOENZYME MIMICS WITH ATOMIC METAL CENTERS

Guo, Quanyi/参与

贵州医科大学附属医院

ADVANCED MATERIALS 34 (16): - APR 2022

MATERIALS SCIENCE

95

2022

高被引论文

41

RESEARCH ON THE CONSTRUCTION OF PORTABLE ELECTROCHEMICAL SENSORS FOR ENVIRONMENTAL

He, Quanguo/第一作者;Liu, Jun;
Liu, Hongmei/通讯作者

贵州医科大学

MATERIALS TODAY ADVANCES 17: - MAR 2023

MATERIALS SCIENCE

95

2023

高被引论文

42

PREVALENCE OF STROKE IN CHINA, 2013-2019: A POPULATION-BASED STUDY

Chu, Lan/参与

贵州医科大学附属医院

LANCET REGIONAL HEALTH-WESTERN PACIFIC 28: - NOV 2022

CLINICAL MEDICINE

95

2022

高被引论文

43

TAXONOMY OF THE TRICHOPHYTON MENTAGROPHYTES/T. INTERDIGITALE SPECIES COMPLEX HARBORING THE HIGHLY VIRULENT, MULTIRESISTANT GENOTYPE T. INDOTINEAE

Tang, Chao/第一作者;Kang, Yingqian/通讯作者

贵州医科大学

MYCOPATHOLOGIA 186 (3): 315-326 JUN 2021

PLANT & ANIMAL SCIENCE

94

2021

高被引论文

44

EXOSOME-DERIVED FGD5-AS1 PROMOTES TUMOR-ASSOCIATED MACROPHAGE M2 POLARIZATION-MEDIATED PANCREATIC CANCER CELL PROLIFERATION AND METASTASIS

He, Zhiwei/第一作者;Sun, Chengyi/通讯作者;Zhu, ChanghaoChen, PengJiang, XueyiChen, Yankun/参与

贵州医科大学附属医院

CANCER LETTERS 548: - NOV 1 2022

CLINICAL MEDICINE

80

2022

高被引论文

45

BREAST CANCER HETEROGENEITY AND ITS IMPLICATION IN PERSONALIZED PRECISION THERAPY

Luo, Lan/参与

贵州医科大学附属医院

EXPERIMENTAL HEMATOLOGY & ONCOLOGY 12 (1): - JAN 9 2023

CLINICAL MEDICINE

68

2023

高被引论文

46

GLOBAL TRENDS AND FORECASTS OF BREAST CANCER INCIDENCE AND DEATHS

Xu, Yuyan/第一作者;
Zeng, Qibing
Liu, Shu/通讯作者;Gong, MaoyuanWang, YueYang, Yang/参与

贵州医科大学;
贵州医科大学附属医院

SCIENTIFIC DATA 10 (1): - MAY 27 2023

CLINICAL MEDICINE

65

2023

高被引论文

47

FINAL OVERALL SURVIVAL ANALYSIS OF GEMCITABINE AND CISPLATIN INDUCTION CHEMOTHERAPY IN NASOPHARYNGEAL CARCINOMA: A MULTICENTER, RANDOMIZED PHASE III TRIAL

Jin, Feng/参与

贵州医科大学附属医院

JOURNAL OF CLINICAL ONCOLOGY 40 (22): 2420-+ AUG 1 2022

CLINICAL MEDICINE

60

2022

高被引论文

48

DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS: CHALLENGES AND RECENT DEVELOPMENTS

Cheng, Mingrong/参与

贵州医科大学第三附属医院

JOURNAL OF BIOMEDICAL SCIENCE 30 (1): - JUN 19 2023

CLINICAL MEDICINE

57

2023

高被引论文、热点论文

49

CIRCRNA SAMD4 INDUCES CARDIAC REPAIR AFTER MYOCARDIAL INFARCTION BY BLOCKING MITOCHONDRIA-DERIVED ROS OUTPUT

Si, Xiaoyun/参与

贵州医科大学附属医院

MOLECULAR THERAPY 30 (11): 3477-3498 NOV 2 2022

CLINICAL MEDICINE

54

2022

高被引论文

50

TREATMENT WITH NIRAPARIB MAINTENANCE THERAPY IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED OVARIAN CANCER A PHASE 3 RANDOMIZED CLINICAL TRIAL

Yang, Yingjie/参与

贵州医科大学附属医院

JAMA ONCOLOGY 9 (9): 1230-1237 SEP 2023

CLINICAL MEDICINE

53

2023

高被引论文

51

ADVANCES IN MECHANISM AND REGULATION OF PANOPTOSIS: PROSPECTS IN DISEASE TREATMENT

Li, ShiJin/参与

贵州医科大学

FRONTIERS IN IMMUNOLOGY 14: - FEB 9 2023

IMMUNOLOGY

49

2023

高被引论文

52

EXPLORING THE MECHANISM OF CD UPTAKE AND TRANSLOCATION IN RICE: FUTURE PERSPECTIVES OF RICE SAFETY

Zhao, Zhenjie/参与

贵州医科大学

SCIENCE OF THE TOTAL ENVIRONMENT 897: - NOV 1 2023

ENVIRONMENT/ECOLOGY

48

2023

高被引论文

53

LONG-TERM EXPOSURE TO AMBIENT PM2.5 AND ITS COMPONENTS ASSOCIATED WITH DIABETES: EVIDENCE FROM A LARGE POPULATION-BASED COHORT FROM CHINA

Hong, Feng/通讯作者

贵州医科大学

DIABETES CARE 46 (1): 111-119 JAN 2023

CLINICAL MEDICINE

43

2023

高被引论文

54

TORIPALIMAB PLUS CHEMOTHERAPY FOR RECURRENT OR METASTATIC NASOPHARYNGEAL CARCINOMA THE JUPITER-02 RANDOMIZED CLINICAL TRIAL

Jin, Feng/参与

贵州医科大学附属医院

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 330 (20): 1961-1970 NOV 28 2023

CLINICAL MEDICINE

40

2023

高被引论文

55

NK CELL-DERIVED EXOSOMES ENHANCE THE ANTI-TUMOR EFFECTS AGAINST OVARIAN CANCER BY DELIVERING CISPLATIN AND REACTIVATING NK CELL FUNCTIONS

Luo, Heyong/第一作者;
Zhao, Xing
Zeng, Zhu/通讯作者

贵州医科大学

FRONTIERS IN IMMUNOLOGY 13: - JAN 19 2023

IMMUNOLOGY

32

2023

高被引论文

56

REAL-WORLD EFFICACY AND PROGNOSTIC FACTORS OF LENVATINIB PLUS PD-1 INHIBITORS IN 378 UNRESECTABLE HEPATOCELLULAR CARCINOMA PATIENTS

Lei, Jin/参与

贵州医科大学

HEPATOLOGY INTERNATIONAL 17 (3): 709-719 JUN 2023

CLINICAL MEDICINE

30

2023

高被引论文

57

DO ALL FUNGI HAVE ANCESTORS WITH ENDOPHYTIC LIFESTYLES?

Bhunjun, Chitrabhanu S./第一作者;Li, Qirui/通讯作者

贵州医科大学

FUNGAL DIVERSITY 125 (1): 73-98 SP. ISS. SI MAR 2024

PLANT & ANIMAL SCIENCE

27

2024

高被引论文

58

EFFICACY AND SAFETY OF CIPROFOL VS. PROPOFOL FOR THE INDUCTION AND MAINTENANCE OF GENERAL ANAESTHESIA A MULTICENTRE, SINGLE-BLIND, RANDOMISED, PARALLEL-GROUP, PHASE 3 CLINICAL TRIAL

Zou, Xiaohua/参与

贵州医科大学附属医院

EUROPEAN JOURNAL OF ANAESTHESIOLOGY 40 (6): 399-406 JUN 2023

CLINICAL MEDICINE

26

2023

高被引论文

59

METRNL ALLEVIATES LIPID ACCUMULATION BY MODULATING MITOCHONDRIAL HOMEOSTASIS IN DIABETIC NEPHROPATHY

Zhou, Yuxia/第一作者;Yan, RuiGuo, Bing/通讯作者

贵州医科大学;
贵州医科大学附属医院

DIABETES 72 (5): 611-626 MAY 2023

CLINICAL MEDICINE

25

2023

高被引论文

60

DRUG REPURPOSING FOR CANCER THERAPY

Xia, Ying/第一作者;Huang, Hai/通讯作者

贵州医科大学;
贵州医科大学附属医院

SIGNAL TRANSDUCTION AND TARGETED THERAPY 9 (1): - APR 19 2024

MOLECULAR BIOLOGY & GENETICS

25

2024

高被引论文、热点论文

61

FUNGAL DIVERSITY NOTES 1611-1716: TAXONOMIC AND PHYLOGENETIC CONTRIBUTIONS ON FUNGAL GENERA AND SPECIES EMPHASIS IN SOUTH CHINA

Li, Qi-Rui/参与

贵州医科大学

FUNGAL DIVERSITY 122 (1): 161-403 SEP 2023

PLANT & ANIMAL SCIENCE

24

2023

高被引论文、热点论文

62

INDUCTION-CONCURRENT CHEMORADIOTHERAPY WITH OR WITHOUT SINTILIMAB IN PATIENTS WITH LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA IN CHINA (CONTINUUM) : A MULTICENTRE, OPEN-LABEL, PARALLEL-GROUP, RANDOMISED, CONTROLLED, PHASE 3BTRIAL

Wu, Wei-Li/参与

贵州医科大学附属医院

LANCET 403 (10445): 2720-2731 JUN 22 2024

CLINICAL MEDICINE

13

2024

高被引论文、热点论文

63

NRF2 DEFICIENCY PROMOTES FERROPTOSIS OF ASTROCYTES MEDIATED BY OXIDATIVE STRESS IN ALZHEIMERS DISEASE

Tang, Zhi/第一作者;Qi, Xiaolan
/通讯作者

贵州医科大学

MOLECULAR NEUROBIOLOGY 61 (10): 7517-7533 OCT 2024

NEUROSCIENCE & BEHAVIOR

12

2024

高被引论文

64

HER2-TARGETED THERAPIES IN CANCER: A SYSTEMATIC REVIEW

Yang, XinyiTai, Hebei/参与

贵州医科大学

BIOMARKER RESEARCH 12 (1): - FEB 2 2024

CLINICAL MEDICINE

10

2024

高被引论文

65

CAUSAL RELATIONSHIP BETWEEN IMMUNE CELLS AND NEURODEGENERATIVE DISEASES: A TWO-SAMPLE MENDELIAN RANDOMISATION STUDY

Tang, Chao/第一作者;
He, Dian
/通讯作者

贵州医科大学附属医院

FRONTIERS IN IMMUNOLOGY 15: - JAN 29 2024

IMMUNOLOGY

10

2024

高被引论文

66

IDENTIFYING PROLIFERATIVE HEPATOCELLULAR CARCINOMA AT PRETREATMENT CT: IMPLICATIONS FOR THERAPEUTIC OUTCOMES AFTER TRANSARTERIAL CHEMOEMBOLIZATION

Li, Jun-Xiang/第二作者;Wang, Li -Zhou/参与

贵州医科大学附属医院

RADIOLOGY 308 (2): - AUG 2024

CLINICAL MEDICINE

10

2024

高被引论文

67

TEA CONSUMPTION AND ATTENUATION OF BIOLOGICAL AGING: A LONGITUDINAL ANALYSIS FROM TWO COHORT STUDIES

Wang, Ziyun/参与

贵州医科大学

LANCET REGIONAL HEALTH-WESTERN PACIFIC 42: - JAN 2024

CLINICAL MEDICINE

9

2024

高被引论文

68

ICARITIN WITH AUTOPHAGY/MITOPHAGY INHIBITORS SYNERGISTICALLY ENHANCES ANTICANCER EFFICACY AND APOPTOTIC EFFECTS THROUGH PINK1/PARKIN-MEDIATED MITOPHAGY IN HEPATOCELLULAR CARCINOMA

Gong, Zipeng/参与;Wang, Jigang
/通讯作者

贵州医科大学

CANCER LETTERS 587: - APR 10 2024

CLINICAL MEDICINE

9

2024

高被引论文

69

QUERCETIN SUPPRESSES OVARIECTOMY-INDUCED OSTEOPOROSIS IN RAT MANDIBLES BY REGULATING AUTOPHAGY AND THE NLRP3 PATHWAY

Xiong, Yue/第一作者;
Xiong, Yue;
Liao, Jian/通讯作者

贵州医科大学附属口腔医院;贵州医科大学

EXPERIMENTAL BIOLOGY AND MEDICINE 248 (23): 2363-2380 DEC 2023

CLINICAL MEDICINE

7

2023

高被引论文

70

EFFECT OF PROLONGED COOKING AT LOW TEMPERATURES ON THE EATING QUALITY OF TIBETAN PORK: MEAT QUALITY, WATER DISTRIBUTION, AND MICROSTRUCTURE

Li, Xiefei/第二作者;Huang, Qun/通讯作者

贵州医科大学

FOOD QUALITY AND SAFETY 8: - JUL 18 2024

AGRICULTURAL SCIENCES

6

2024

热点论文



贵州医科大学图书馆学科服务部

2025123


版权所有 贵州医科大学图书馆©2014-2015
地址:贵州省贵安新区安康大道6号贵州医科大学图书馆 
邮编:561113    邮箱:tsg@gmc.edu.cn  
  联系电话:0851-88593218

  • 图书馆微信公众平台

  • 图书馆读者QQ群